T-Detect COVID is authorized under the FDA Emergency Use Authorization (EUA).

Want to know if you had an immune response to the virus that causes COVID-19?

T cells have the answer.*

Want to know if you had an immune response to the virus that causes COVID-19?

T cells have the answer.*

Opt In Email

Be the first to know about T-Detect news, offers and updates.

Sign Up

Get the test

Order Patient

1. Order

Answer some eligibility questions and submit payment.
Order now.

Account Set Up

2. Test authorization

An independent healthcare provider will review your responses and, if appropriate, authorize your test.

Blood Draw

3. Blood draw

A certified phlebotomist will draw your blood.

Results

4. Results

Adaptive Biotechnologies will process the blood sample and share results with you via a secure email from PWNHealth.

Estimated time for test results is 7-10 days from the time of your blood draw.

Adaptive has partnered with PWNHealth, an independent healthcare provider network, to authorize tests, when appropriate.

Why T cells?

  • T cells are the first responders of the adaptive immune system.
  • T-cell responses can persist in the blood long after antibody responses wane.1, 2
  • High specificity: Each T cell recognizes a very specific piece of the virus. All of your T cells together (your T-cell response) can see many parts of the virus. Most antibody tests only look for one part of the virus (e.g., spike protein).3
  • In a study, T-cell responses were detected up to 15 months after initial COVID-19 infection with 86% sensitivity.4

Time since infection

T cells persist longer than antibodies

* Based on prior research on other coronavirus T-cell responses. 2, 5

Patients Specificity Data

Specificity of a test is its ability to designate an individual who does not have a disease as negative. A highly specific test means that there are few false positive results.

T cells vs. antibodies

In some studies, T-cell testing outperformed leading antibody tests.6,7

Sensitivity

Patients Data Sensitivity

Sensitivity based on positive percent agreement (PPA) with PCR testing.
Sensitivity refers to a test’s ability to designate an individual with disease as positive. A highly sensitive test means that there are few false negative results, and thus fewer cases of disease are missed.

References

  1. Tay MZ, et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020.
  2. Ng O, et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016.
  3. Zuo J, et al. Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021.
  4. Gittelman, et al. Longitudinal analysis of T-cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection. medRxiv. 2022.
  5. Channappanavar R, et al. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 2014.
  6. Dalai S, et al. Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection. medRxiv. 2021.
  7. Elyanow R., et al. T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity. medRxiv. 2021.

*The performance of T-Detect COVID has not been established in individuals that have received a COVID-19 vaccine.

T-Detect COVID is not FDA cleared or approved. It is authorized for emergency use under an Emergency Use Authorization (EUA). T-Detect is not indicated for use in patients under age 18.